RUBY REBORN TRANSFUSION DNA KIT- glycerin liquid

Ruby ReBorn Transfusion DNA Kit by

Drug Labeling and Warnings

Ruby ReBorn Transfusion DNA Kit by is a Otc medication manufactured, distributed, or labeled by Karatica Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Glycerin

INACTIVE INGREDIENT

Adenosine, Ruby, Diamond, DNA, etc

PURPOSE

Anti-Wrinkle

KEEP OUT OF REACH OF CHILDREN

keep out or reach of the children

INDICATIONS & USAGE

Take appropriate amount and evenly apply it to the skin

1. Open the lid of the vial and remove aluminum thread carefully
2. Insert vial in serter in the vial.
3. Drop the fomula on wrinkles around eyes and mouth and the entire face. Then use your fingertips to help formula to be absorbed into the skin.

WARNINGS

If you experience following symptoms after using the cosmetics, you should immediately stop using the cosmetics. If you continue to use them, the symptoms may worsen. Consult with your dermatologist.
A) When you experience red spots, swelling, itchiness and irritation while applying the product.
B) When the applied area experience symptoms while it is exposed to direct sunlight
2. Do not use the cosmetics on the areas where you have wounds, eczema or dermatitis
3. Precautions when storing and using the product
A) Keep the lid closed after using the product
B) Store it out of reach of children
C) Do not store it in places with high or low temperature or where it is exposed to the sunlight directly.

DOSAGE & ADMINISTRATION

for external use only

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

RUBY REBORN TRANSFUSION DNA KIT 
glycerin liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70514-0004
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX)	GLYCERIN	7 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
ADENOSINE (UNII: K72T3FS567)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70514-0004-1	22 mL in 1 AMPULE; Type 0: Not a Combination Product	12/05/2017

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part347	11/29/2017

Labeler - Karatica Co., Ltd (689605545)

Registrant - Karatica Co., Ltd (689605545)

Establishment
Name	Address	ID/FEI	Business Operations
Karatica Co., Ltd		689605545	manufacture(70514-0004)